Nestle To Become No. 1 In China's Infant Formula Market Following Pfizer Nutrition Acquisition
This article was originally published in PharmAsia News
With roughly 60% of Pfizer Nutrition sales coming from Asia, and 47% of that from China, Nestle slips into No. 1 spot in China’s infant formula market.